Nanochon is leading the charge in the field of medical technology, reimagining the landscape of joint injury treatment. Their inventive implant not only restores damaged cartilage but also fosters fresh tissue growth. Utilizing cutting-edge 3-D printing technology and groundbreaking material, Nanochon's implant serves as both a resilient orthopedic load-bearing device and a scaffold for tissue regeneration. This advancement is poised to redefine patient recoveries, trim healthcare costs, and establish new benchmarks in cartilage rehabilitation.

Listen now via your favorite podcast platforms:

Apple: https://apple.co/3TSYK4n
Google: https://bit.ly/3HcFMOu
Spotify:https://spoti.fi/3RXXvhU
Amazon Music: https://amzn.to/41XdNvR
TuneIn: https://bit.ly/3NOtq2W 

In this episode, we learn about Nanochon's beginnings, the uniqueness of their technology, the individuals constituting their team, their funding strategies, and the challenges they've overcome.

Don't miss this episode as we venture into the frontier of advanced medical solutions with Nanochon. Tune in now and be part of the conversation reshaping the future of joint health.

Benjamin Holmes is the CEO at Nanochon. Benjamin Holmes attended The George Washington University – School of Engineering & Applied Science. He has experience in tissue engineering, 3D printing, biomaterials, nanotechnology and medical devices. He co-founded Nanochon in 2016, and has led the company through R&D, pre-clinical product development and non-dilutive and dilutive fundraising. He has prior and additional medical device startup experience, notably with commercial-stage device company SonoStik.